Not all clients with CLL demand therapy. Despite all modern improvements, the iwCLL still recommends watchful observation for patients with asymptomatic disorder.86 This suggestion relies on at least two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).助成事業完�